SCHEMBL8306342

SCHEMBL8306342

OCCO/N=C/c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 2/20 0.47
NPC1 O15118 1/20 0.46
GAA P10253 1/20 0.46
RAB9A P51151 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
PLA2G7 Q13093 1/20 0.46
ATM Q13315 1/20 0.45
UNG P13051 2/20 0.43
LMNA P02545 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC2 Q92769 1/20 0.43
ALDH1A1 P00352 1/20 0.42
RECQL P46063 1/20 0.42
PPARG P37231 6/20 0.42
PPARA Q07869 6/20 0.42
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
GRIN2D O15399 1/20 0.38
GRIN3B O60391 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8306343 1.00 TAAR1 (0.47) TAAR1NPC1GAARAB9ASMN1; SMN2
SCHEMBL8308913 0.89 HDAC2 (0.54) TAAR1NPC1GAARAB9ASMN1; SMN2
SCHEMBL8308910 0.89 HDAC2 (0.54) TAAR1NPC1GAARAB9ASMN1; SMN2
SCHEMBL8305044 0.85 UNG (0.46) TAAR1NPC1GAARAB9ASMN1; SMN2
SCHEMBL8305043 0.85 UNG (0.46) TAAR1NPC1GAARAB9ASMN1; SMN2
SCHEMBL8309124 0.81 TAAR1 (0.42) TAAR1NPC1GAARAB9ASMN1; SMN2
SCHEMBL8309123 0.81 TAAR1 (0.42) TAAR1NPC1GAARAB9ASMN1; SMN2
SCHEMBL14262702 0.81 PLA2G7 (0.45) NPC1RAB9ASMN1; SMN2PLA2G7LMNA
SCHEMBL8307151 0.79 ALDH1A1 (0.54) GAASMN1; SMN2LMNAL3MBTL1ALDH1A1
SCHEMBL8307153 0.79 ALDH1A1 (0.54) GAASMN1; SMN2LMNAL3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5972959-A Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1999-10-26 US disclosed
EP-0708098-B1 Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1999-03-03 EP disclosed
US-5780490-A A O-(2,4-OXA(OR THIA)ZOLIDINYL)PHENYLOXY(OR THIO OR AMINO) ALKYLOXIME; ALDOSE REDUCTASE INHIBITORS; ANTIDIABETIC AND -HYPOGLYCEMIC AGENTS; LIVER, SKIN AND UROGENITAL DISORDERS SANKYO COMPANY, LIMITED (JP) 1998-07-14 US disclosed
US-5703096-A ANTIDIABETIC AGENTS; ALDOSE REDUCTASE INHIBITOR SANKYO COMPANY, LIMITED (JP) 1997-12-30 US disclosed
EP-0708098-A1 Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-04-24 EP disclosed